SYNCOM

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2021.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on Jun 30, 2021.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on February 14, 2021.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on December 07, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on December 07, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on September 15, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on Jun 23, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 23, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on Jun 17, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on May 30, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on February 14, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on May 29, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on January 16, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2017.This is to inform you that the Board of Directors at its meeting held today i.e. 14th November 2017 on Tuesday at 07:00 P.M. at the registered office of the Company and concluded at 10:15 P.M. considered, approved and adopted unaudited standalone financial results of the Company for the financial quarter and half year ended on 30th September , 2017.A copy of the statement of the unaudited standalone financial results alongwith the Independent Limited Review Report in this regard ar

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 10, 2017.This is to inform you that the Board of Directors at its meeting held today i.e. 10th June 2017 on Monday at 7:10 P.M. and concluded at 06:00 P.M. at the registered office of the Company, inter alia have considered and approved the Unaudited Standalone financial Results of the Company for the first quarter ended 30th June, 2017.The Limited Review of the Financial Results has been done by the Statutory Auditors of the Company.In this Connection, please find enclosed Unaudited standalone

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2017.In terms of Regulation 30 read Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that, the meeting of the Board of Directors of our Company was held today i.e. on Tuesday, May 30, 2017 at 4:30 P.M., time scheduled for the meeting and concluded at 8:15 P.M. at the registered office of the Company

Syncom Healthcare Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on December 31, 2016.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2016.

Syncom Healthcare Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on June 20, 2016.

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2016, concluded and inter-alia transacted the following business:1. It has accepted the Resignation of Mr. Ajay Shankarlal Bankda from the office of Director and Managing director of the company.2. The Company has appointed Mr. Pratik Bankda as an additional director of the Company and also as a Managing Director of the Company subject to approval by members in general meeting.3. The Company has appointed Mrs. Manju Khandelwal as an independent director of the Company.

Syncom Healthcare Limited has informed the Exchange that Outcome of Board Meeting

Syncom Healthcare Limited has informed the Exchange that the meeting of the Board of Directors has been called on November 12, 2014 and approved the following businesses: a) Appointment of Mr. Bhishampal Singh Yadav as Director of the Company effective from November 12, 2014. b) Appointment of Mrs. Sunita Garg as Independent Director of the Company effective from November 12, 2014. c) Resignation of Mr. Jagdish Prasad Bagaria from the Directorship of the Company effective from November 12, 2014. d) Appointment of Mr. Tushar Patodia as Independent Director of the Company effective from Nove

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 22, 2014, for approving the resignation of :1. Shri Goviddas Pasari, Independent Director of the Company from the position of directors of the Company and,2. Shri Bharat Kumar Doshi, Independent Director of the Company from the position of directors of the Company.

Syncom Healthcare Limited has informed the Exchange that the Meeting of the Board of Directors of the Company held on August 14, 2014, has transacted the following business: 1. The Board has approved appointment of Mr. Manish Maheshwari, Practicing Company Secretary as a Scrutinizer for e-voting. 2. The Board has approved appointment of M/s. M Maheshwari & Associates, Practicing Company Secretary for Secretarial Audit for the financial year 2014-15.

Syncom Healthcare Limited has informed the Exchange that the Board of Directors in its meeting held on July 07, 2010 has inter alia transacted the following : (1) Increase in the Authorised Share Capital to Rs. 40 Crores from the present Authorised Share Capital of Rs. 20 Crores and also to make necessary amendments in Memorandum of Association and Articles of Association of the Company; (2) Raising of additional funds through issue of securities; (3) Increase in the limits for FII investment; (4) Authority to investment, give loan and extend guarantee; (5) Authority to the Board under Section